SANGAMO THERAPEUTICS, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
SANGAMO THERAPEUTICS, INC. (SGMOQ) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $3.85 million as of 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-03-30
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3.85M.
- 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6.21M.
- 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6.88M.
- 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $9.17M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $3.85M 10-K · filed 2026-03-30 |
| 2024-12-31 | $6.21M 10-K · filed 2025-03-17 |
| 2023-12-31 | $6.88M 10-K · filed 2024-03-13 |
| 2022-12-31 | $9.17M 10-K · filed 2023-02-23 |
| 2021-12-31 | $11.76M 10-K · filed 2022-02-24 |
| 2021-09-30 | $9.69M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $10.33M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $10.98M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $11.34M 10-K · filed 2021-02-24 |
| 2020-09-30 | $11.71M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $12.36M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $13.02M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $13.71M 10-K · filed 2020-02-28 |
| 2019-09-30 | $13.98M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $14.67M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $7.85M 10-Q · filed 2019-05-08 |